Kedrion Biopharma - USA reposted this
✨ What makes Kedrion more than just a business? 🌍 It's our incredible global community of dedicated people, united by shared values and a powerful mission to help those suffering from serious and rare health conditions. 💪 Meet our colleagues as they explain the shared values that drive us: https://lnkd.in/dP8JnpX5 #WeAreKedrion #TogetherWeGrow #annualreport #respect
🌟 Exciting News! 🌟 Kedrion Biopharma Inc. is thrilled to sponsor the National Bleeding Disorders Foundation's (NBDF) 76th Annual Bleeding Disorders Conference (BDC) in Atlanta, Georgia, taking place from September 12-14, 2024! This event brings together individuals with bleeding and or clotting disorders, their families, healthcare professionals, and researchers from across the country to connect, learn, and grow. At Kedrion, our commitment to the rare disorders community runs deep. As a leading manufacturer of coagulation and rare disease therapies, we are dedicated to providing patients with access to innovative treatments that improve lives. We're proud to have presented two medical publications and for our Kim Clark, PharmD, MBA, IgCP, Medical Affairs Excellence and Capabilities Lead to facilitate sessions titled Hereditary Factor X Deficiency in America Survey: Results & Discussion and Plasminogen Deficiency Foundation - PLGD-1 Roundtable at this year’s conference. Additionally, we were honored to be part of Rare Realities – PLGD-1: Renae’s Story. Our very own Bob Rossilli, CCO delivered opening remarks in multiple sessions, showcasing our leadership and commitment to this vital cause. Together, we are stronger. 💙 #BleedingDisorders #ClottingDisorders #KedrionBiopharma #NBDF #BDC2024 #RareDiseases #FactorX #PatientCare #InnovativeTherapies #HealthcareLeadership
🌟 Celebrating Our Commitment to Patients Worldwide! 🌟 At Kedrion we work tirelessly to bring plasma derived therapies to the patients who need them. In our recently published 2023 Annual Report we reflect on a year of progress, growth and challenges. We boosted R&D and increased capacities in efforts to make treatments available for more patients. Join us in celebrating this remarkable journey! 🙌 Together, we’re making a difference one milestone at a time. #WeAreKedrion #TogetherWeGrow #AnnualReport #Plasma https://lnkd.in/dP8JnpX5
